178 related articles for article (PubMed ID: 26924533)
1. The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis.
Peveling-Oberhag J; Arcaini L; Bankov K; Zeuzem S; Herrmann E
J Viral Hepat; 2016 Jul; 23(7):536-44. PubMed ID: 26924533
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management.
Peveling-Oberhag J; Arcaini L; Hansmann ML; Zeuzem S
J Hepatol; 2013 Jul; 59(1):169-77. PubMed ID: 23542089
[TBL] [Abstract][Full Text] [Related]
3. The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection.
Mahale P; Engels EA; Li R; Torres HA; Hwang LY; Brown EL; Kramer JR
Gut; 2018 Mar; 67(3):553-561. PubMed ID: 28634198
[TBL] [Abstract][Full Text] [Related]
4. Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma.
Merli M; Carli G; Arcaini L; Visco C
World J Gastroenterol; 2016 Oct; 22(38):8447-8458. PubMed ID: 27784957
[TBL] [Abstract][Full Text] [Related]
5. Most patients with HCV-associated lymphoma present with mild liver disease: a call to revise antiviral treatment prioritization.
Torres HA; Mahale P
Liver Int; 2015 Jun; 35(6):1661-4. PubMed ID: 25779000
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus infection and non-hepatocellular malignancies in the DAA era: A systematic review and meta-analysis.
Masarone M; Persico M
Liver Int; 2019 Jul; 39(7):1292-1306. PubMed ID: 30983083
[TBL] [Abstract][Full Text] [Related]
7. miRNA-26b downregulation in peripheral blood mononuclear cells of patients with hepatitis C associated lymphomas is restored by successful interferon-free antiviral therapy.
Peveling-Oberhag J; Bankov K; Dultz G; Ballo O; Lohmeyer J; Brunnberg U; Marcu V; Walter D; Zeuzem S; Hansmann ML; Welzel TM; Vermehren J
Antivir Ther; 2019; 24(6):437-442. PubMed ID: 31180334
[TBL] [Abstract][Full Text] [Related]
8. Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network.
Rattotti S; Ferretti VV; Rusconi C; Rossi A; Fogazzi S; Baldini L; Pioltelli P; Balzarotti M; Farina L; Ferreri AJM; Laszlo D; Speziale V; Varettoni M; Sciarra R; Morello L; Tedeschi A; Frigeni M; Defrancesco I; Zerbi C; Flospergher E; Nizzoli ME; Morra E; Arcaini L;
Hematol Oncol; 2019 Apr; 37(2):160-167. PubMed ID: 30726562
[TBL] [Abstract][Full Text] [Related]
9. Antiviral therapy improves overall survival in hepatitis C virus-infected patients who develop diffuse large B-cell lymphoma.
Hosry J; Mahale P; Turturro F; Miranda RN; Economides MP; Granwehr BP; Torres HA
Int J Cancer; 2016 Dec; 139(11):2519-28. PubMed ID: 27501007
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus - associated B cell non-Hodgkin's lymphoma.
Mihăilă RG
World J Gastroenterol; 2016 Jul; 22(27):6214-23. PubMed ID: 27468211
[TBL] [Abstract][Full Text] [Related]
11. Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection.
Arcaini L; Besson C; Frigeni M; Fontaine H; Goldaniga M; Casato M; Visentini M; Torres HA; Loustaud-Ratti V; Peveling-Oberhag J; Fabris P; Rossotti R; Zaja F; Rigacci L; Rattotti S; Bruno R; Merli M; Dorival C; Alric L; Jaccard A; Pol S; Carrat F; Ferretti VV; Visco C; Hermine O
Blood; 2016 Nov; 128(21):2527-2532. PubMed ID: 27605512
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C Virus-Associated B-Cell Non-Hodgkin's Lymphoma: Clinical and Therapeutic Challenges.
Russi S; Sansonno L; Sansonno D
Curr Drug Targets; 2017; 18(7):766-771. PubMed ID: 26844565
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus infection and B-cell non-Hodgkin's lymphoma: a cross-sectional study in Lyon, France.
Sève P; Renaudier P; Sasco AJ; Dumontet C; Salles G; Coiffier B; Zoulim F; Broussolle C; Trépo C
Eur J Gastroenterol Hepatol; 2004 Nov; 16(12):1361-5. PubMed ID: 15618846
[TBL] [Abstract][Full Text] [Related]
14. Concomitant therapy with direct-acting antivirals and chemoimmunotherapy in HCV-associated diffuse large B-cell lymphoma.
Occhipinti V; Farina L; Viganò M; Capecchi M; Labanca S; Fanetti I; Corradini P; Rumi M
Dig Liver Dis; 2019 May; 51(5):719-723. PubMed ID: 30502232
[TBL] [Abstract][Full Text] [Related]
15. From hepatitis C virus infection to B-cell lymphoma.
Couronné L; Bachy E; Roulland S; Nadel B; Davi F; Armand M; Canioni D; Michot JM; Visco C; Arcaini L; Besson C; Hermine O
Ann Oncol; 2018 Jan; 29(1):92-100. PubMed ID: 29045541
[TBL] [Abstract][Full Text] [Related]
16. Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy.
Arcaini L; Merli M; Volpetti S; Rattotti S; Gotti M; Zaja F
Clin Dev Immunol; 2012; 2012():638185. PubMed ID: 22956970
[TBL] [Abstract][Full Text] [Related]
17. High sustained virological response to pegylated interferon and ribavirin for recurrent genotype 3 hepatitis C infection post-liver transplantation.
Faisal N; Mumtaz K; Marquez M; Renner EL; Lilly LB
Hepatol Int; 2015 Jan; 9(1):76-83. PubMed ID: 25788382
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas.
Silvestri F; Barillari G; Fanin R; Pipan C; Falasca E; Salmaso F; Zaja F; Infanti L; Patriarca F; Botta GA; Baccarani M
Haematologica; 1997; 82(3):314-7. PubMed ID: 9234578
[TBL] [Abstract][Full Text] [Related]
19. Viral and non-viral risk factors for non-Hodgkin's lymphoma in Egypt: heterogeneity by histological and immunological subtypes.
Goldman L; Ezzat S; Mokhtar N; Abdel-Hamid A; Fowler N; Gouda I; Eissa SA; Abdel-Hamid M; Loffredo CA
Cancer Causes Control; 2009 Aug; 20(6):981-7. PubMed ID: 19263231
[TBL] [Abstract][Full Text] [Related]
20. HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents.
Carrier P; Jaccard A; Jacques J; Tabouret T; Debette-Gratien M; Abraham J; Mesturoux L; Marquet P; Alain S; Sautereau D; Essig M; Loustaud-Ratti V
Liver Int; 2015 Oct; 35(10):2222-7. PubMed ID: 26104059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]